Pulmonary Arterial Hypertension (PAH) Therapeutics Market to Reach USD 13.5 Bn by 2028, rising at a CAGR of 5.4% - Global Analysis by TMR
08 mai 2023 08h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, May 08, 2023 (GLOBE NEWSWIRE) -- The pulmonary arterial hypertension (PAH) therapeutics market was valued at USD 5.2 Bn in 2020, and is projected to reach USD...